Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

Dalfampridine
(D04127)

[1] Dalfampridine

[1] Dalfampridine (D04127) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[2] 4, 13 💬

Dalfampridine ER
(D04127)

[1] Dalfampridine

[1] Dalfampridine (D04127) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

Dalfampridine ER, 10 MG oral tablet, extended release
(D04127)

[1] Dalfampridine

[1] Dalfampridine (D04127) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

Dalfampridine plus physical therapy
(D04127)

[1] Dalfampridine

[1] Dalfampridine (D04127) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

Dalfampridine-ER 10MG
(D04127)

[1] Dalfampridine

[1] Dalfampridine (D04127) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

Dalfampridine-ER 5MG
(D04127)

[1] Dalfampridine

[1] Dalfampridine (D04127) 💬

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[1] 13 💬

Sustained-release oral dalfampridine
(D04127)

[1] 13 💬

Withdrawal OF dalfampridine-ER 10MG
(D04127)

[1] 13 💬